Mobile

Double-blind, partially randomized, parallel group, multicenter study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having c...

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001548-60

Double-blind, partially randomized, parallel group, multicenter study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial BM16549

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To study the effect of long-term treatment with monthly oral ibandronate 100 mg and 150 mg, given as a single tablet, on lumbar spine and hip BMD and bone turnover and to assess the overall long-term tolerability and safety of the treatment regimens.

Critère d'inclusion

  • Long term study in women with postmenopausal osteoporosis

Liens